Election 2014
SENSEX NIFTY

Dsp Merrill Lynch

Apr 21, 2014 at 09:14 | Source: CNBC-TV18
Jyotivardhan Jaipuria, Bank of America Merrill Lynch says the voter turnout so far has been substantially higher than that of the previous Lok Sabha elections in 2009. We think this has led the market to believe that opinion polls that showed a strong BJP and NDA, he adds.
Apr 19, 2014 at 16:11 | Source: Moneycontrol.com
Earnings would be in focus in US with nearly one-third of S&P 500 names set to post results this week. As regards to macro data, the main data would be the latest manufacturing sector purchasing managers indices (PMI) due out in the Eurozone and China, on Wednesday.
Apr 17, 2014 at 15:36 | Source: CNBC
Ting Lu, chief China economist at Bank of America Merrill Lynch said the case for a universal RRR cut - which merely increases interbank liquidity - is "quite weak" as money market rates remain low.
Apr 15, 2014 at 16:33 | Source: PTI
BofA-ML said in near-term, the path of CPI inflation, will be determined by rising El Nino risks. For March, it expects CPI inflation to rise to 8.4 percent as against 8.1 percent last month.
Apr 07, 2014 at 12:14 | Source: Moneycontrol.com
Jyotivardhan Jaipuria, Bank of America Merrill Lynch says with elections the key focus for markets, earnings may not be a big market moving event.
Apr 05, 2014 at 12:51 | Source: Moneycontrol.com
On April 04, 2014 Nomura Singapore Limited bought 20,99,439 shares of Ansal Properties & Infrastructure at Rs 17.40.
Apr 03, 2014 at 17:31 | Source: CNBC-TV18
After 10-day of incessant rally, one will often hear advises like "do not sell Indian equities just yet," "buy at every dip" on Dalal Street.
Apr 03, 2014 at 09:24 | Source: Moneycontrol.com
Laurence Balanco, CLSA says the Nifty is 'overbought' in the short-term. While the market is vulnerable to a short-term pullback, it is likely to be short-lived and followed by new highs, he adds.
Apr 02, 2014 at 13:18 | Source: Moneycontrol.com
The brokerage has raised 12-month target price on the stock by 25 percent to Rs 311. It feels that Mothersons sales visibility is strong and may register 20 percent CAGR through FY20. "Its margins may expand 300 basis points to 12.5 percent in FY16E and 40 percent increase in order inflows in FY14E," it adds.
Mar 31, 2014 at 14:04 | Source: CNBC-TV18
Indranil Sengupta, chief economist India, Bank of America Merrill Lynch expects CPI to come down to 7-7.5 percent by March 2015 on the back of stable rainfall. If not, food prices may rise. He says in case of an El-Nino, CPI may once again get stuck in the 8-10 percent range.
Messages on Dsp Merrill Lynch »

livelovelau
gh

Platinum Member

314 Followers

Fresenius Kabi  

Transfer your shares in an off market mode to the DP, DSP Merrill lynch ltd(dp id IN 302638 ,client id 10067756)as mentioned in the document. attach the xerox of instruction slip duly stamped by your dp to duly filled exit offer from and send it to link in time ,Mumbai or hand deliver it.

11.57 AM Jan 10th

BSE/NSE Announcer

Platinum Member

2365 Followers

Fresenius Kabi  

DSP Merrill Lynch, manager to the Delisting Offer, on behalf of Fresenius Kabi (Singapore) Pte Ltd has informed this exit offer Public Announcement to the Equity Shareholders of the Fresenius Kabi Oncology.

1.35 PM Dec 31st 2013

BSE/NSE Announcer

Platinum Member

2365 Followers

Fresenius Kabi  

DSP Merrill Lynch Ltd ("Manager to the Delisting Offer") on behalf of Fresenius Kabi (Singapore) Pte Ltd (“Acquirer”) has informed this Exit Offer Public Announcement ("Exit Offer PA") to the Equity Shareholders of the Fresenius Kabi Oncology Limited (“Company”). This Exit Offer PA provide

1.19 PM Dec 31st 2013

BSE/NSE Announcer

Platinum Member

2365 Followers

Fresenius Kabi  

DSP Merrill Lynch Limited has submitted to the Exchange a copy of Exit offer Public Announcement made by Fresenius Kabi (Singapore) Pte Ltd to the public shareholders of Fresenius Kabi Oncology Limited ("company") ("Delisting Offer").

1.27 PM Dec 30th 2013

man

Platinum Member

371 Followers

Fresenius Kabi  

as to costs.” All the other terms and conditions of the PA and the Letter of Offer remain unchanged. Date: October 21, 2013 ISSUED BY THE MANAGER TO THE DELISTING OFFER ON BEHALF OF THE ACQUIRER DSP Merrill Lynch Limited Registered Office: 8th Floor, Mafatlal Centre, Nariman Point, Mumbai- 400 021

6.24 PM Nov 9th 2013

phirozaban

Platinum Member

65 Followers

Fresenius Kabi  

Lincoln: Pl read the DSP Merrill Lynch notification particularly para reproduced here for your perusal."Appeal No. 133 of 2013 was disposed of by our order dated September 10, 2013. This Tribunal while allowing appeal had set aside condition attached to impugned order of SEBI dated July 22, 2013

1.43 PM Nov 1st 2013

BSE/NSE Announcer

Platinum Member

2365 Followers

Fresenius Kabi  

DSP Merrill Lynch Ltd ("Manager to the Delisting Offer") on behalf of Fresenius Kabi (Singapore) Pte Ltd (“Acquirer”) has informed this Supplement to the Second Corrigendum to the Public Announcement ("Supplement to the Second Corrigendum") to the Public Announcement published on September 16, 2013

5.51 PM Oct 22nd 2013

BSE/NSE Announcer

Platinum Member

2365 Followers

Fresenius Kabi  

DSP Merrill Lynch Limited has submitted to the Exchange a copy of the Supplement to the Second Corrigendum ("Corrigendum") to the Public Announcement issued pertaining to the delisting offer made by Fresenius Kabi (Singapore) Pte Ltd to the public shareholders of Fresenius Kabi Oncology Limited

12.51 PM Oct 22nd 2013

BSE/NSE Announcer

Platinum Member

2365 Followers

Fresenius Kabi  

DSP Merrill Lynch, manager to the delisting offer on behalf of Fresenius Kabi (Singapore) Pte Ltd (Acquirer) has informed this public corrigendum to the Public Delisting Announcement to the shareholders of Fresenius Kabi Oncology.

12.05 PM Oct 14th 2013

BSE/NSE Announcer

Platinum Member

2365 Followers

Fresenius Kabi  

DSP Merrill Lynch Limited has informed the Exchange regarding Corrigendum ("Corrigendum") to the Public Announcement issued pertaining to the delisting offer made by Fresenius Kabi (Singapore) Pte Ltd to the public shareholders of Fresenius Kabi Oncology Limited ("company") ("Delisting Offer").

11.33 AM Oct 14th 2013

News across the web »
Mar 18, 2014 at 18:41 | Source: Economic Times
Feb 02, 2014 at 12:27 | Source: Economic Times
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.